Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Brisbane, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Tempest Therapeutics, Inc. has filed 1,021 SEC EDGAR filings since 09 Apr 2012

SEC filing history

Showing 576-600 of 1,000 matching filings.

Per page
25
Current page
24
S-8 File 333-216405

S-8

Filing date
02 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
02 Mar 2017
Reporting date
02 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

ORBIS INVESTMENT MANAGEMENT LIMITED

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

13G AMENDMENT

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

ADAGE CAPITAL PARTNERS GP, L.L.C.

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87213

SC 13G filing

Filing date
30 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35890

CT ORDER filing

Filing date
27 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

OVAS12.31.16

Filing date
26 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

SC 13G/A filing

Filing date
10 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
10 Jan 2017
Reporting date
09 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
10 Jan 2017
Reporting date
05 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
09 Jan 2017
Reporting date
05 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87213

13G AMENDED MONTHLY FILING - OVAS

Filing date
09 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jan 2017
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jan 2017
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jan 2017
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jan 2017
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
23 Dec 2016
Reporting date
21 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-214414

S-8

Filing date
03 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-214413

S-3

Filing date
03 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35890

8-K

Filing date
03 Nov 2016
Reporting date
03 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2016
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .